EU Committee OKs More Pharma-Friendly Compulsory Licensing Plan

The rapporteur for the draft EU legislation says it will help to balance the public health interests of European citizens with the need for the pharma industry to keep innovating.

Patent files and documents in cabinet in office. 3D rendered illustration.
Patented drugs could be subject to EU-level compulsory licensing • Source: Shutterstock

The European Parliament’s legal affairs committee (JURI) has approved a draft EU regulation that would allow the European Commission to issue compulsory licenses to improve access to crisis-relevant medicines in times of health emergencies.

More from Europe

More from Geography